✦ LIBER ✦

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial

✍ Scribed by M. Kaufmann; N. Maass; S.D. Costa; A. Schneeweiß; S. Loibl; M.W. Sütterlin; I. Schrader; B. Gerber; W. Bauer; W. Wiest; O. Tomé; A. Distelrath; V. Hagen; A. Kleine-Tebbe; E. Ruckhaeberle; K. Mehta; G. von Minckwitz

Book ID: 116430474
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 555 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.07.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity and safety of vinorelbine and c

Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer – a phase II trial

✍ R. Palumbo; A. Bernardo; M. Strada; C. Teragni; G. Poggi; M. Frascaroli; A. Amat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Use of Capecitabine as First-Line Therap

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

427 POSTER The TEXAS trial — mature resu

427 POSTER The TEXAS trial — mature results of activity/toxicity of taxotere given with anthracyclines in a community setting, as first line therapy for metastatic breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

The Breast Avastin Trial: phase II study

The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer

✍ Bisagni, G.; Musolino, A.; Panebianco, M.; Matteis, A.; Nuzzo, F.; Ardizzoni, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB

A Phase II Trial of Split, Low-Dose Doce

A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast Cancer

✍ Orlando Silva; Gilberto Lopes; Daniel Morgenzstern; Christopher Lobo; Philomena 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

Phase II study with dose finding of Oral

Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study

✍ F. Nolè; Catania; G. Sanna; R. Mattioli; D. Crivellari; P. Foa; G. Pinotti; D. L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB